⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine EU August 3, 2023

Victoza

📷 Wikipedia: Liraglutide · Source
Victoza
📷 Wikipedia: Liraglutide · Source
INN
liraglutide
Forms
Pre-filled pen
Strengths
6 mg/ml
Area
Diabetes Mellitus, Type 2
Alternatives
Yes
🗄
Archived (older alert)
This alert was reported 1090 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
73 days in total
May 16, 2026 July 28, 2026

What is this? Victoza is a medicine for type 2 diabetes. It comes as a pen you inject.

What's happening? There is a shortage of Victoza pens in the EU. Other diabetes medicines are available.

Does this affect me? If you use Victoza, your supply may be limited. Check with your pharmacist.

What should I do? Ask your pharmacist or doctor about a different medicine or plan. Do not stop taking your medicine without advice.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
liraglutide
Brand(s) / product name(s)
Victoza
Agency-published detail

INN: liraglutide · Forms: Pre-filled pen · Strengths: 6 mg/ml · Area: Diabetes Mellitus, Type 2 · Alternatives: Yes

First published
August 3, 2023
Last refreshed by us
1 hour ago
Severity (as classified)
High
Official source
https://www.ema.europa.eu/en/medicines/human/shortages/victoza

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Victoza. INN: liraglutide · Forms: Pre-filled pen · Strengths: 6 mg/ml · Area: Diabetes Mellitus, Type 2 · Alternatives: Yes
▸ When was this alert issued?
This alert was issued on August 3, 2023 by EMA (European Medicines Agency).
▸ Which countries are affected?
The alert applies to the entire EU.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on www.ema.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.